Increasing daily consumption of flavonoid-rich foods may lower dementia risk

Research shows that flavonoid-rich diets, including tea and red wine, are associated with a lower risk of dementia in genetically susceptible individuals.

Eisai and Biogen’s subcutaneous Leqembi set for FDA review – Pharmaceutical Technology

Eisai and Biogen’s antibody is currently infused every two weeks at hospitals and dedicated infusion sites. Image credit: Shutterstock/ AtlasStudio. Eisai and Biogen are one

January 14, 2025

Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment

February 27, 2024

How Endpoints covers AI, and a chance to hear from two Nobel winners

More than a year ago, Endpoints News made the decision that we needed a dedicated reporter covering the use of artificial intelligence in drug R&D.

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.